SEC Form D · filed December 4, 2023
Graviton BioScience Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
James D. Boylan · New York, NYDirectorJeremy D. Levin · New York, NYDirectorDavid D. Macmillan · Princeton, NJDirectorSamuel D. Waksal · New York, NYExec · DirectorBihua D. Chen · Boston, MADirectorRan D. Nussbaum · Herzliya, L3DirectorStelios D. Papadopoulos · New York, NYDirectorJeremy D. Levin · New York, NYDirectorDavid D. Macmillan · Princeton, NJDirectorRan D. Nussbaum · Herzliya, L3DirectorJames D. Boylan · New York, NYDirectorStelios D. Papadopoulos · New York, NYDirectorBihua D. Chen · Boston, MADirectorSamuel D. Waksal · New York, NYExec · DirectorJoel Barthelemy · Phoenix, AZDirectorMaxim Capital Partners, LLC · New York, NYDirectorMaxim Capital Group, LLC · New York, NYExec · DirectorDamian Vila · Manati, Puerto RicoDirectorNolen S. Taylor · Denver, CODirectorCooper Jordan · ATLANTIC CITY, NJDirectorCharles Clinton · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗